市場調查報告書

臨床實驗藥包裝的全球市場:2020年∼2024年

Clinical Trial Packaging Market by End-user and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 922439
出版日期 內容資訊 英文 146 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床實驗藥包裝的全球市場:2020年∼2024年 Clinical Trial Packaging Market by End-user and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年12月20日內容資訊: 英文 146 Pages
簡介

全球臨床實驗藥包裝市場在2020年∼2024年的預測期間內,預計將以4%以上的年複合成長率增長,達到6億6,692萬美元的規模。新藥認證的增加是促進成長的要素。還有人工智能在臨床研究中的出現也有望推動全球研究性藥物包裝市場的增長。

本報告提供全球臨床實驗藥包裝市場相關調查分析,提供市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2019年∼2024年)
  • 製藥公司
  • 其他組織
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 臨床研究上AI的出現
  • CRO外包活動的增加
  • 醫藥品生產的雲端技術採用及檢驗的增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Bilcare Ltd.
  • Caligor Coghlan Pharma Services
  • Corden Pharma International GmbH
  • Mawdsley-Brooks & Co. Ltd.
  • PCI Pharma Services
  • Piramal Enterprises Ltd.
  • Sentry BioPharma Services
  • Sharp
  • The WestRock group
  • Thermo Fisher Scientific Inc.

第14章 附錄

  • 調查方法
  • 簡稱清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40182

Technavio has been monitoring the global clinical trial packaging market, and it is poised to grow by USD667.92 million during 2020-2024, progressing at a CAGR of over 4% during the forecast period. Our reports on global clinical trial packaging market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing approval of novel drugs. Also, the advent of AI in clinical research is anticipated to boost the growth of the global clinical trial packaging market as well.

Market Segmentation

Technavio's global clinical trial packaging market is segmented as below:

End-users

  • Pharmaceutical companies
  • Organizations

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global clinical trial packaging market growth

This study identifies advent of AI in clinical research as the prime reason driving the global clinical trial packaging market growth during the next few years.

Prominent vendors in global clinical trial packaging market

We provide a detailed analysis of around 25 vendors operating in the global clinical trial packaging market, including some of the vendors such as Bilcare Ltd., Caligor Coghlan Pharma Services, Corden Pharma International GmbH, Mawdsley-Brooks & Co. Ltd., PCI Pharma Services, Piramal Enterprises Ltd., Sentry BioPharma Services, Sharp, The WestRock group and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical companies - Market size and forecast 2019-2024
  • Other organizations - Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Advent of AI in clinical research
  • Increasing outsourcing activities to CROs
  • Increasing adoption of cloud technologies in pharmaceutical production
  • and testing

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bilcare Ltd.
  • Caligor Coghlan Pharma Services
  • Corden Pharma International GmbH
  • Mawdsley-Brooks & Co. Ltd.
  • PCI Pharma Services
  • Piramal Enterprises Ltd.
  • Sentry BioPharma Services
  • Sharp
  • The WestRock group
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Vendors: Key offerings
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: End-user - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by end-user
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Top 3 countries in North America
  • Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 33: Top 3 countries in Europe
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Top 3 countries in Asia
  • Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 39: Top 3 countries in ROW
  • Exhibit 40: Key leading countries
  • Exhibit 41: Market opportunity
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Bilcare Ltd. - Vendor overview
  • Exhibit 49: Bilcare Ltd. - Business segments
  • Exhibit 50: Bilcare Ltd. - Key offerings
  • Exhibit 51: Bilcare Ltd. - Key customers
  • Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview
  • Exhibit 53: Caligor Coghlan Pharma Services - Business segments
  • Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments
  • Exhibit 55: Caligor Coghlan Pharma Services - Key offerings
  • Exhibit 56: Caligor Coghlan Pharma Services - Key customers
  • Exhibit 57: Corden Pharma International GmbH - Vendor overview
  • Exhibit 58: Corden Pharma International GmbH - Business segments
  • Exhibit 59: Corden Pharma International GmbH - Organizational developments
  • Exhibit 60: Corden Pharma International GmbH - Key offerings
  • Exhibit 61: Corden Pharma International GmbH - Key customers
  • Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview
  • Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments
  • Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments
  • Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings
  • Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers
  • Exhibit 67: PCI Pharma Services - Vendor overview
  • Exhibit 68: PCI Pharma Services - Business segments
  • Exhibit 69: PCI Pharma Services - Organizational developments
  • Exhibit 70: PCI Pharma Services - Key offerings
  • Exhibit 71: PCI Pharma Services - Key customers
  • Exhibit 72: Piramal Enterprises Ltd. - Vendor overview
  • Exhibit 73: Piramal Enterprises Ltd. - Business segments
  • Exhibit 74: Piramal Enterprises Ltd. - Organizational developments
  • Exhibit 75: Piramal Enterprises Ltd. - Segment focus
  • Exhibit 76: Piramal Enterprises Ltd. - Key offerings
  • Exhibit 77: Piramal Enterprises Ltd. - Key customers
  • Exhibit 78: Sentry BioPharma Services - Vendor overview
  • Exhibit 79: Sentry BioPharma Services - Business segments
  • Exhibit 80: Sentry BioPharma Services - Key offerings
  • Exhibit 81: Sentry BioPharma Services - Key customers
  • Exhibit 82: Sharp - Vendor overview
  • Exhibit 83: Sharp - Business segments
  • Exhibit 84: Sharp - Organizational developments
  • Exhibit 85: Sharp - Geographic focus
  • Exhibit 86: Sharp - Key offerings
  • Exhibit 87: Sharp - Key customers
  • Exhibit 88: The WestRock group - Vendor overview
  • Exhibit 89: The WestRock group - Business segments
  • Exhibit 90: The WestRock group - Organizational developments
  • Exhibit 91: The WestRock group - Segment focus
  • Exhibit 92: The WestRock group - Key offerings
  • Exhibit 93: The WestRock group - Key customers
  • Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 95: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 100: Thermo Fisher Scientific Inc. - Key customers
  • Exhibit 101: Validation techniques employed for market sizing
  • Exhibit 102: Definition of market positioning of vendors
Back to Top